205 related articles for article (PubMed ID: 8894667)
21. Elucidating the underlying molecular pathogenesis of NR3C2 mutants causing autosomal dominant pseudohypoaldosteronism type 1.
Riepe FG; Finkeldei J; de Sanctis L; Einaudi S; Testa A; Karges B; Peter M; Viemann M; Grötzinger J; Sippell WG; Fejes-Toth G; Krone N
J Clin Endocrinol Metab; 2006 Nov; 91(11):4552-61. PubMed ID: 16954160
[TBL] [Abstract][Full Text] [Related]
22. Mineralocorticoid resistance.
Zennaro MC; Lombès M
Trends Endocrinol Metab; 2004 Aug; 15(6):264-70. PubMed ID: 15358279
[TBL] [Abstract][Full Text] [Related]
23. A novel nonsense mutation of the mineralocorticoid receptor gene in the renal form of pseudohypoaldosteronism type 1.
Uchida N; Shiohara M; Miyagawa S; Yokota I; Mori T
J Pediatr Endocrinol Metab; 2009 Jan; 22(1):91-5. PubMed ID: 19344080
[TBL] [Abstract][Full Text] [Related]
24. Pseudohypoaldosteronism.
Riepe FG
Endocr Dev; 2013; 24():86-95. PubMed ID: 23392097
[TBL] [Abstract][Full Text] [Related]
25. Identification of a novel mutation in the human mineralocorticoid receptor gene in a german family with autosomal-dominant pseudohypoaldosteronism type 1: further evidence for marked interindividual clinical heterogeneity.
Riepe FG; Krone N; Morlot M; Ludwig M; Sippell WG; Partsch CJ
J Clin Endocrinol Metab; 2003 Apr; 88(4):1683-6. PubMed ID: 12679457
[TBL] [Abstract][Full Text] [Related]
26. Autosomal dominant pseudohypoaldosteronism type 1: mechanisms, evidence for neonatal lethality, and phenotypic expression in adults.
Geller DS; Zhang J; Zennaro MC; Vallo-Boado A; Rodriguez-Soriano J; Furu L; Haws R; Metzger D; Botelho B; Karaviti L; Haqq AM; Corey H; Janssens S; Corvol P; Lifton RP
J Am Soc Nephrol; 2006 May; 17(5):1429-36. PubMed ID: 16611713
[TBL] [Abstract][Full Text] [Related]
27. A novel mutation of the epithelial Na+ channel causes type 1 pseudohypoaldosteronism.
Bonny O; Knoers N; Monnens L; Rossier BC
Pediatr Nephrol; 2002 Oct; 17(10):804-8. PubMed ID: 12376807
[TBL] [Abstract][Full Text] [Related]
28. Familial Hyperkalemia and Hypertension (FHHt) and KLHL3: Description of a Family with a New Recessive Mutation (S553L) Compared to a Family with a Dominant Mutation, Q309R, with Analysis of Urinary Sodium Chloride Cotransporter.
Kliuk-Ben Bassat O; Carmon V; Hanukoglu A; Ganon L; Massalha E; Holtzman EJ; Farfel Z; Mayan H
Nephron; 2017; 137(1):77-84. PubMed ID: 28511177
[TBL] [Abstract][Full Text] [Related]
29. Different inactivating mutations of the mineralocorticoid receptor in fourteen families affected by type I pseudohypoaldosteronism.
Sartorato P; Lapeyraque AL; Armanini D; Kuhnle U; Khaldi Y; Salomon R; Abadie V; Di Battista E; Naselli A; Racine A; Bosio M; Caprio M; Poulet-Young V; Chabrolle JP; Niaudet P; De Gennes C; Lecornec MH; Poisson E; Fusco AM; Loli P; Lombès M; Zennaro MC
J Clin Endocrinol Metab; 2003 Jun; 88(6):2508-17. PubMed ID: 12788847
[TBL] [Abstract][Full Text] [Related]
30. Pseudohypoaldosteronism type 1 due to a novel mutation in the mineralocorticoid receptor gene.
Loomba-Albrecht LA; Nagel M; Bremer AA
Horm Res Paediatr; 2010; 73(6):482-6. PubMed ID: 20453518
[TBL] [Abstract][Full Text] [Related]
31. Growth hormone activates renin-aldosterone system in children with idiopathic short stature and in a pseudohypoaldosteronism patient with a mutation in epithelial sodium channel alpha subunit.
Hanukoglu A; Belutserkovsky O; Phillip M
J Steroid Biochem Mol Biol; 2001 Apr; 77(1):49-57. PubMed ID: 11358674
[TBL] [Abstract][Full Text] [Related]
32. The functional c.-2G>C variant of the mineralocorticoid receptor modulates blood pressure, renin, and aldosterone levels.
van Leeuwen N; Caprio M; Blaya C; Fumeron F; Sartorato P; Ronconi V; Giacchetti G; Mantero F; Fernandes-Rosa FL; Simian C; Peyrard S; Zitman FG; Penninx BW; de Kloet ER; Azizi M; Jeunemaitre X; Derijk RH; Zennaro MC
Hypertension; 2010 Nov; 56(5):995-1002. PubMed ID: 20855654
[TBL] [Abstract][Full Text] [Related]
33. Polymorphisms of amiloride-sensitive sodium channel subunits in five sporadic cases of pseudohypoaldosteronism: do they have pathologic potential?
Arai K; Zachman K; Shibasaki T; Chrousos GP
J Clin Endocrinol Metab; 1999 Jul; 84(7):2434-7. PubMed ID: 10404817
[TBL] [Abstract][Full Text] [Related]
34. 30 YEARS OF THE MINERALOCORTICOID RECEPTOR: Mineralocorticoid receptor mutations.
Zennaro MC; Fernandes-Rosa F
J Endocrinol; 2017 Jul; 234(1):T93-T106. PubMed ID: 28348114
[TBL] [Abstract][Full Text] [Related]
35. Familial pseudohypoaldosteronism.
Popow C; Pollak A; Herkner K; Scheibenreiter S; Swoboda W
Acta Paediatr Scand; 1988 Jan; 77(1):136-41. PubMed ID: 2967023
[TBL] [Abstract][Full Text] [Related]
36. Molecular characterization of the mineralocorticoid receptor in pseudohypoaldosteronism.
Zennaro MC; Borensztein P; Jeunemaitre X; Armanini D; Corvol P; Soubrier F
Steroids; 1995 Jan; 60(1):164-7. PubMed ID: 7792806
[TBL] [Abstract][Full Text] [Related]
37. Mutations in the mineralocorticoid receptor gene cause autosomal dominant pseudohypoaldosteronism type I.
Geller DS; Rodriguez-Soriano J; Vallo Boado A; Schifter S; Bayer M; Chang SS; Lifton RP
Nat Genet; 1998 Jul; 19(3):279-81. PubMed ID: 9662404
[TBL] [Abstract][Full Text] [Related]
38. Case report: severe neonatal hyperkalemia due to pseudohypoaldosteronism type 1.
Schweiger B; Moriarty MW; Cadnapaphornchai MA
Curr Opin Pediatr; 2009 Apr; 21(2):269-71. PubMed ID: 19657313
[TBL] [Abstract][Full Text] [Related]
39. Pseudohypoaldosteronism due to renal and multisystem resistance to mineralocorticoids respond differently to carbenoxolone.
Hanukoglu A; Joy O; Steinitz M; Rosler A; Hanukoglu I
J Steroid Biochem Mol Biol; 1997 Jan; 60(1-2):105-12. PubMed ID: 9182864
[TBL] [Abstract][Full Text] [Related]
40. Functional polymorphisms in the mineralocorticoid receptor and amirolide-sensitive sodium channel genes in a patient with sporadic pseudohypoaldosteronism.
Arai K; Nakagomi Y; Iketani M; Shimura Y; Amemiya S; Ohyama K; Shibasaki T
Hum Genet; 2003 Jan; 112(1):91-7. PubMed ID: 12483305
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
